181 related articles for article (PubMed ID: 16942000)
1. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
[TBL] [Abstract][Full Text] [Related]
2. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
3. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
Ogawa H; Kameda H; Amano K; Takeuchi T
Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.
Castro M; Ugolini-Lopes M; Borba EF; Bonfá E; Seguro LPC
Lupus; 2018 Dec; 27(14):2215-2219. PubMed ID: 30394834
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
Fu LW; Yang LY; Chen WP; Lin CY
Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
[TBL] [Abstract][Full Text] [Related]
9. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
Kasitanon N; Boripatkosol P; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of lupus nephritis with cyclosporin A.
Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
[TBL] [Abstract][Full Text] [Related]
11. Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis.
Sawamura M; Sawa N; Ikuma D; Oba Y; Yamanouchi M; Sekine A; Mizuno H; Hasegawa E; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Ubara Y
Intern Med; 2023 Apr; 62(7):1037-1041. PubMed ID: 36070938
[TBL] [Abstract][Full Text] [Related]
12. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
Ogawa H; Kameda H; Nagasawa H; Sekiguchi N; Takei H; Tsuzaka K; Amano K; Takeuchi T
Mod Rheumatol; 2007; 17(2):92-7. PubMed ID: 17437162
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[TBL] [Abstract][Full Text] [Related]
15. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.
Aragon E; Chan YH; Ng KH; Lau YW; Tan PH; Yap HK
Lupus; 2010 Jul; 19(8):965-73. PubMed ID: 20581019
[TBL] [Abstract][Full Text] [Related]
16. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
17. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
Touma Z; Urowitz MB; Ibañez D; Gladman DD
J Rheumatol; 2014 Apr; 41(4):688-97. PubMed ID: 24429170
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.
Hallegua D; Wallace DJ; Metzger AL; Rinaldi RZ; Klinenberg JR
Lupus; 2000; 9(4):241-51. PubMed ID: 10866094
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
